Literature DB >> 8567334

An analysis of mandibular bone complications in radiotherapy for T1 and T2 carcinoma of the oral tongue.

M Fujita1, Y Hirokawa, K Kashiwado, Y Akagi, K Kashimoto, H Kiriu, K Ohtani, T Wada.   

Abstract

PURPOSE: To examine the incidence of mandibular bone complication in patients who underwent radiotherapy for T1 and T2 carcinomas of the oral tongue and to analyze the factors contributing to its occurrence. METHODS AND MATERIALS: The clinical records of 148 patients with T1 and T2 carcinoma of the oral tongue treated with radiotherapy alone between 1978 and 1989 were examined retrospectively. Interstitial brachytherapy, used as the major treatment modality, was performed using cobalt needles, radium needles, or iridium hairpins. The prescribed dose at the plane 5 mm from the plane of the radioactive sources was 65-70 Gy in interstitial brachytherapy alone, and 50-60 Gy in the combined treatment with external irradiation. An external irradiation dose of 30 Gy was usually used.
RESULTS: Eleven of the patients showed radiation-induced mandibular bone complication. Two (1 T1, 1 T2) had been treated with interstitial brachytherapy alone, and nine (2 T1, 7 T2) with the combination of external irradiation and interstitial brachytherapy. The incidence of radiation complication of bone was significantly higher in the patients with T2 tumors (p = 0.04) and in those who received the combined treatment (p < 0.01). Multivariate analysis revealed that the total dose (p = 0.04) and dose rate of interstitial brachytherapy (p = 0.03) were significant factors contributing to radiation bone complication. A significant difference in the incidence of bone complication was also seen between patients who received a total dose of 90 Gy or more and those who received less than 90 Gy (p < 0.01), as well as between patients who were treated with 0.55 Gy/h or higher and those who were treated with less than 0.55 Gy/h (p = 0.03).
CONCLUSION: A significant increase in the incidence of bone complication was found at the total dose of 90 Gy or more and at the dose rate of 0.55 Gy/h or higher. In combined treatment with external irradiation and interstitial brachytherapy, the interstitial brachytherapy dose of 60 Gy appears to be the threshold at which mandibular bone complication is induced when the external irradiation dose is 30 Gy.

Entities:  

Mesh:

Year:  1996        PMID: 8567334     DOI: 10.1016/0360-3016(95)02066-7

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  9 in total

Review 1.  Osteoradionecrosis in cancer patients: the evidence base for treatment-dependent frequency, current management strategies, and future studies.

Authors:  Douglas E Peterson; Wolfgang Doerr; Allan Hovan; Andres Pinto; Debbie Saunders; Linda S Elting; Fred K L Spijkervet; Michael T Brennan
Journal:  Support Care Cancer       Date:  2010-06-06       Impact factor: 3.603

2.  Experience of high-dose-rate brachytherapy for head and neck cancer treated by a customized intraoral mold technique.

Authors:  Kenichi Obinata; Keiichi Ohmori; Hiroki Shirato; Motoyasu Nakamura
Journal:  Radiat Med       Date:  2007-05-28

3.  Proton Therapy for Mandibula Plate Phantom.

Authors:  Güler Burcu Senirkentli; Fatih Ekinci; Erkan Bostanci; Mehmet Serdar Güzel; Özlem Dağli; Ahmed M Karim; Alok Mishra
Journal:  Healthcare (Basel)       Date:  2021-02-04

4.  Effect of a lead block on alveolar bone protection in image-guided high-dose-rate interstitial brachytherapy for tongue cancer: using model-based dose calculation algorithms to correct for inhomogeneity.

Authors:  Hironori Akiyama; Ken Yoshida; Tadashi Takenaka; Tadayuki Kotsuma; Koji Masui; Hajime Monzen; Iori Sumida; Yutaka Tsujimoto; Mamoru Miyao; Hiroki Okumura; Taiju Shimbo; Hideki Takegawa; Naoya Murakami; Koji Inaba; Tairo Kashihara; Zoltán Takácsi-Nagy; Nikolaos Tselis; Hideya Yamazaki; Eiichi Tanaka; Keiji Nihei; Yoshiko Ariji
Journal:  J Contemp Brachytherapy       Date:  2022-02-04

5.  Investigating the displacement of radio-active sources during gold-198 grain brachytherapy for hospitalized oral cancer patients.

Authors:  Masaru Konishi; Yuki Takeuchi; Katsumaro Kubo; Nobuki Imano; Ikuno Nishibuchi; Yuji Murakami; Kiichi Shimabukuro; Pongsapak Wongratwanich; Naoya Kakimoto; Yasushi Nagata
Journal:  J Contemp Brachytherapy       Date:  2022-03-23

6.  Preventing Complications from High-Dose Rate Brachytherapy when Treating Mobile Tongue Cancer via the Application of a Modular Lead-Lined Spacer.

Authors:  Shumei Murakami; Rinus G Verdonschot; Naoya Kakimoto; Iori Sumida; Masateru Fujiwara; Kazuhiko Ogawa; Souhei Furukawa
Journal:  PLoS One       Date:  2016-04-29       Impact factor: 3.240

7.  Long-term outcome of high-dose-rate brachytherapy and perioperative brachytherapy in early mobile tongue cancer.

Authors:  Mahadev Potharaju; Hemanth Raj E; Manavalan Muthukumaran; Murali Venkataraman; Bhargavi Ilangovan; Selvan Kuppusamy
Journal:  J Contemp Brachytherapy       Date:  2018-02-28

8.  A 16-gene signature predicting prognosis of patients with oral tongue squamous cell carcinoma.

Authors:  Zeting Qiu; Wei Sun; Shaowei Gao; Huaqiang Zhou; Wulin Tan; Minghui Cao; Wenqi Huang
Journal:  PeerJ       Date:  2017-11-17       Impact factor: 2.984

9.  Treatment outcomes of real-time intraoral sonography-guided implantation technique of 198Au grain brachytherapy for T1 and T2 tongue cancer.

Authors:  Masaru Konishi; Minoru Fujita; Yuki Takeuchi; Katsumaro Kubo; Nobuki Imano; Ikuno Nishibuchi; Yuji Murakami; Kiichi Shimabukuro; Pongsapak Wongratwanich; Rinus Gerardus Verdonschot; Naoya Kakimoto; Yasushi Nagata
Journal:  J Radiat Res       Date:  2021-09-13       Impact factor: 2.724

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.